Exosomal drug delivery

Ended Project Grant Awarded Last action

Award ID
R44CA221487
Recipient
Awarding agency
Obligated
$1,719,680

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Place of performance
Kentucky, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Exosomal drug delivery - technical abstract as with many chemotherapeutic drugs, taxanes exhibit poor oral bioavailability; hence, they are administered… $0
Amendment $0
Amendment $1,000,000
Amendment $719,679
Original award $1

Quick answers

Who received award R44CA221487?

R44CA221487 was awarded to 3P Biotechnologies, Inc. by National Cancer Institute (National Institutes of Health) on September 26, 2017.

How much is award R44CA221487 worth?

$1,719,680 has been obligated on R44CA221487.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award